NexPlasmaGen Incorporée
$119,200.00 CAD
≈ 18 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- September 2, 2019 – March 31, 2021
- Reference
- nrc-cnrc:172-2019-2020-Q3-935250
Published purpose
This project enhances the development of a unique high precision cold plasma device as a adjuvant for breast cancer radiotherapy. More particularly, the detailed design, fabrication and commissioning of this prototype will be performed so that it can be used in clinical trials in Canada.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions